🇺🇸 FDA
Patent

US 7829074

Hydroxypatite-targeting poly(ethylene glycol) and related polymers

granted A61KA61K31/715A61K47/18

Quick answer

US patent 7829074 (Hydroxypatite-targeting poly(ethylene glycol) and related polymers) held by Nektar Therapeutics expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/715, A61K47/18, A61K47/24, A61K47/60